Press Release | December 8, 2022
Dragonfly Therapeutics Announces First Patient Dosed in Phase 1 Study of its EGFR-targeting TriNKET™
Read More
Press Release | November 24, 2022
Proud to congratulate ImCheck’s scientific founder, Prof. Daniel Olive, on his election as President of the French Society of Immunology
Read More
Press Release | November 15, 2022
ElevateBio and Affini-T Therapeutics Announce Partnership to Advance Affini-T’s T Cell Therapy Programs Targeting Core Oncogenic Drivers
Read More
News | November 14, 2022
Ionis, Metagenomi pen Big Pharma-sized genetic target pact that could total almost $3B
Read More
